Q4 2023 Management View CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed ...

Q4 2024 Earnings Call Transcript February 12, 2025 10x Genomics, Inc. misses on earnings expectations. Reported EPS is $-0.4 ...

The Visium CytAssist is a compact, benchtop instrument that enables the transfer of transcriptomic probes from standard glass slides to Visium slides, enabling spatial profiling insights to be gained ...

Market Open. Project to Provide Cybersecurity to Government and Private Sectors in West Africa FAIRFAX, VA / ACCESSWIRE / June 25, 2024 / Visium Technologies, Inc., ("Visium" or the "Company ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales reorganization and grow base of industry users.

Sponsored Cyber Attackers Continue To Play Whack-A-Mole, But Defense Is Getting Better — Is Visium An Example For Partnerships In The Cybersecurity World? This post contains sponsored ...

Fuel your spatial discoveries with spatial capture technology which powers the Visium Spatial platform through the use of spatially barcoded mRNA-binding oligonucleotides. There are two methods for ...

Find the latest Visium Technologies, Inc. VISM analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Envision New Dimensions: Introducing the Visium Spatial Gene Expression Solution from thescientistllc on Vimeo. The ability to discern spatial gene expression differences in complex biological systems ...